Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 15

1.

Current knowledge and future research directions in treatment-related second primary malignancies.

Morton LM, Swerdlow AJ, Schaapveld M, Ramadan S, Hodgson DC, Radford J, van Leeuwen FE.

EJC Suppl. 2014 Jun;12(1):5-17. doi: 10.1016/j.ejcsup.2014.05.001. Epub 2014 May 29.

2.

Efficacy of dose escalation on TCP, recurrence and second cancer risks: a mathematical study.

Manem VS, Dhawan A, Kohandel M, Sivaloganathan S.

Br J Radiol. 2014 Nov;87(1043):20140377. doi: 10.1259/bjr.20140377. Epub 2014 Sep 11.

3.

Multiple neoplasms, single primaries, and patient survival.

Amer MH.

Cancer Manag Res. 2014 Mar 5;6:119-34. doi: 10.2147/CMAR.S57378. eCollection 2014.

4.

Breast cancer risk following Hodgkin lymphoma radiotherapy in relation to menstrual and reproductive factors.

Cooke R, Jones ME, Cunningham D, Falk SJ, Gilson D, Hancock BW, Harris SJ, Horwich A, Hoskin PJ, Illidge T, Linch DC, Lister TA, Lucraft HH, Radford JA, Stevens AM, Syndikus I, Williams MV; England and Wales Hodgkin Lymphoma Follow-up Group, Swerdlow AJ.

Br J Cancer. 2013 Jun 11;108(11):2399-406. doi: 10.1038/bjc.2013.219. Epub 2013 May 7.

5.

Risk of second breast cancer in female Hodgkin's lymphoma survivors: a meta-analysis.

Ibrahim EM, Abouelkhair KM, Kazkaz GA, Elmasri OA, Al-Foheidi M.

BMC Cancer. 2012 May 28;12:197. doi: 10.1186/1471-2407-12-197.

6.

Characteristics and outcomes of breast cancer in women with and without a history of radiation for Hodgkin's lymphoma: a multi-institutional, matched cohort study.

Elkin EB, Klem ML, Gonzales AM, Ishill NM, Hodgson D, Ng AK, Marks LB, Weidhaas J, Freedman GM, Miller RC, Constine LS, Myrehaug S, Yahalom J.

J Clin Oncol. 2011 Jun 20;29(18):2466-73. doi: 10.1200/JCO.2010.32.4079. Epub 2011 May 16.

7.

Relationship between radiation exposure and risk of second primary cancers among atomic bomb survivors.

Li CI, Nishi N, McDougall JA, Semmens EO, Sugiyama H, Soda M, Sakata R, Hayashi M, Kasagi F, Suyama A, Mabuchi K, Davis S, Kodama K, Kopecky KJ.

Cancer Res. 2010 Sep 15;70(18):7187-98. doi: 10.1158/0008-5472.CAN-10-0276.

8.

Systematic review: surveillance for breast cancer in women treated with chest radiation for childhood, adolescent, or young adult cancer.

Henderson TO, Amsterdam A, Bhatia S, Hudson MM, Meadows AT, Neglia JP, Diller LR, Constine LS, Smith RA, Mahoney MC, Morris EA, Montgomery LL, Landier W, Smith SM, Robison LL, Oeffinger KC.

Ann Intern Med. 2010 Apr 6;152(7):444-55; W144-54. doi: 10.7326/0003-4819-152-7-201004060-00009. Review.

9.

Breast cancer risk 55+ years after irradiation for an enlarged thymus and its implications for early childhood medical irradiation today.

Adams MJ, Dozier A, Shore RE, Lipshultz SE, Schwartz RG, Constine LS, Pearson TA, Stovall M, Winters P, Fisher SG.

Cancer Epidemiol Biomarkers Prev. 2010 Jan;19(1):48-58. doi: 10.1158/1055-9965.EPI-09-0520.

10.

The UK national breast cancer screening programme for survivors of Hodgkin lymphoma detects breast cancer at an early stage.

Howell SJ, Searle C, Goode V, Gardener T, Linton K, Cowan RA, Harris MA, Hopwood P, Swindell R, Norman A, Kennedy J, Howell A, Wardley AM, Radford JA.

Br J Cancer. 2009 Aug 18;101(4):582-8. doi: 10.1038/sj.bjc.6605215.

11.

Unilateral and bilateral breast cancer in women surviving pediatric Hodgkin's disease.

Basu SK, Schwartz C, Fisher SG, Hudson MM, Tarbell N, Muhs A, Marcus KJ, Mendenhall N, Mauch P, Kun LE, Constine LS.

Int J Radiat Oncol Biol Phys. 2008 Sep 1;72(1):34-40. doi: 10.1016/j.ijrobp.2008.04.068.

12.

Subsequent malignancies in children treated for Hodgkin's disease: associations with gender and radiation dose.

Constine LS, Tarbell N, Hudson MM, Schwartz C, Fisher SG, Muhs AG, Basu SK, Kun LE, Ng A, Mauch P, Sandhu A, Culakova E, Lyman G, Mendenhall N.

Int J Radiat Oncol Biol Phys. 2008 Sep 1;72(1):24-33. doi: 10.1016/j.ijrobp.2008.04.067.

13.

Family history of cancer as a risk factor for second malignancies after Hodgkin's lymphoma.

Andersson A, Enblad G, Tavelin B, Björkholm M, Linderoth J, Lagerlöf I, Merup M, Sender M, Malmer B.

Br J Cancer. 2008 Mar 11;98(5):1001-5. doi: 10.1038/sj.bjc.6604244. Epub 2008 Feb 12.

14.

Increased risk of breast cancer among survivors of allogeneic hematopoietic cell transplantation: a report from the FHCRC and the EBMT-Late Effect Working Party.

Friedman DL, Rovo A, Leisenring W, Locasciulli A, Flowers ME, Tichelli A, Sanders JE, Deeg HJ, Socie G; FHCRC; EBMT-Late Effect Working Party.

Blood. 2008 Jan 15;111(2):939-44. Epub 2007 Oct 2.

15.

A comparison of mantle versus involved-field radiotherapy for Hodgkin's lymphoma: reduction in normal tissue dose and second cancer risk.

Koh ES, Tran TH, Heydarian M, Sachs RK, Tsang RW, Brenner DJ, Pintilie M, Xu T, Chung J, Paul N, Hodgson DC.

Radiat Oncol. 2007 Mar 15;2:13.

Items per page

Supplemental Content

Write to the Help Desk